Details of the Drug Formulaction

General Information of Drug Formulation (ID: F07968)

Formulation Name
Fenofibrate 145 mg tablet
Company
Aurobindo Pharma; NorthStar Rx
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Fenofibrate DMFKXDY Coronary atherosclerosis Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Crospovidone E00626 Not Available Disintegrant
Magnesium stearate E00208 11177 lubricant
Poloxamer 407 E00646 Not Available Emulsifying agent; Solubilizing agent; Surfactant
Polyethylene glycol 400 E00653 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Saccharose E00091 5988 Binding agent; Coating agent; Cryoprotectant; Diluent; Flavoring agent; Suspending agent; Viscosity-controlling agent
Silicon dioxide E00670 Not Available Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate E00464 3423265 Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent